CSX Corporation

The data provided supports a narrow conclusion. Across the eight fiscal years on file, from 2018 through 2025, CSX's revenue ranged from a low of $10.58 billion in 2020 to a high of $14.85 billion in 2022, and 2025 revenue of $14.09 billion sits near the upper part of that range. Operating income has been less steady. It rose to $6.02 billion in 2022, then declined each year to $4.52 billion in 2025, the lowest figure since $4.36 billion in 2020. Operating margin of about 32.1% in 2025 is also below the roughly 39.8% implied by 2018 figures, so the business is converting a smaller share of revenue into operating profit than it did several years earlier. The filings provided do not include MD&A or risk-factor text, so this analysis cannot name the segments, commodity exposures, debt instruments, regulatory matters, or legal proceedings that management or the company's risk disclosures identify as relevant. No forensic scores are on file, so no Beneish M-Score, Piotroski F-Score, Altman Z-Score, or Fog Index reading is reported here. The Beneish M-Score is a screen for patterns that can accompany earnings manipulation, and an elevated reading would call for a closer read rather than prove wrongdoing. The Piotroski F-Score counts how many financial-strength checks a company passes. The Altman Z-Score estimates financial distress risk using a zone label. The Fog Index estimates how hard a document is to read. Each would be informative here, but none can be interpreted without the underlying data. Readers may want to look at the forensic reviews and risk-factor sections of CSX's annual report, and to compare the reported profit decline against management's own explanation of it.

Catalyst.The provided filing data does not include MD&A text, so this section cannot report management's explanation for results. What the reported figures show is a modest revenue decline in 2025: $14.09 billion versus $14.54 billion in 2024, a change of about negative 3.1%. Operating income fell more steeply, from $5.25 billion to $4.52 billion, about negative 13.9%, and net income fell from $3.47 billion to $2.89 billion, about negative 16.7%. Revenue has also declined from its 2022 peak of $14.85 billion. Readers may want to look at the MD&A in CSX's annual report directly to see what management attributes these changes to.

Hidden risk.The most visible tension in these numbers is that profit is falling faster than sales. Operating margin, meaning operating income divided by revenue, moved from about 36.1% in 2024 to about 32.1% in 2025, and net margin moved from about 23.9% to about 20.5%. Net income dropped about 16.7%, more than the 13.9% decline in operating income, which suggests that items below operating income also weighed on results. The data provided does not identify those items. With no risk-factor text, no forensic scores, and no cash flow or balance sheet figures on file, this analysis cannot judge whether the decline is cyclical or structural.